DGX - Quest Diagnostics Inc - SEC Form 4 Insider Trading Screener

Services - Health Services - Medical Laboratories - DGX (1022079)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
31 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2020-04-27
DGXRusckowski Stephen HCOB, CEO, PresS - Sale+OE$112.01-11,717237,747-5%-$1,312,433
2020-04-27
DGXEglinton Manner CarrieSVP, Advanced DiagnosticsS - Sale$111.02-5,00022,390-18%-$555,075
2020-03-16
DGXDavis J. E.EVP, General DiagnosticsS - Sale$87.75-3,51338,086-8%-$308,251
2020-03-11
DGXPrevoznik Michael ESVP, GCS - Sale$104.25-2,17545,196-5%-$226,744
2020-03-11
DGXDoherty Catherine T.SVP, Group Exec. Clin. Fran.S - Sale$104.25-2,50172,414-3%-$260,729
D
2020-03-10
DGXRusckowski Stephen HCOB, CEO, PresS - Sale+OE$112.19-100237,7470%-$11,219
D
2020-03-06
DGXRusckowski Stephen HCOB, CEO, PresS - Sale+OE$112.67-230,178226,560-50%-$25,934,978
M
2020-02-26
DGXPrevoznik Michael ESVP, GCS - Sale$109.68-1,01145,192-2%-$110,884
M
2020-02-26
DGXDoherty Catherine T.SVP, Group Exec. Clin. Fran.S - Sale$109.68-1,15772,415-2%-$126,898
M
2020-02-26
DGXDavis J. E.EVP, General DiagnosticsS - Sale$109.68-1,61038,105-4%-$176,578
2020-02-25
DGXDavis J. E.EVP, General DiagnosticsS - Sale$112.73-59840,902-1%-$67,413
2020-02-25
DGXDoherty Catherine T.SVP, Group Exec. Clin. Fran.S - Sale$112.73-40574,345-1%-$45,656
D
2020-01-02
DGXDavis J. E.EVP, General DiagnosticsS - Sale+OE$105.58-143,53736,543-80%-$15,153,864
D
2019-11-27
DGXPrevoznik Michael ESVP, GCS - Sale+OE$107.43-44,55644,541-50%-$4,786,564
D
2019-11-26
DGXWilensky Gail RDirS - Sale+OE$107.17-8,00028,326-22%-$857,352
D
2019-09-17
DGXDeppe Michael JVP, Corp. Controller, CAOS - Sale+OE$106.00-5,00024,353-17%-$530,000
D
2019-06-13
DGXRusckowski Stephen HCOB, Pres, CEOS - Sale+OE$100.00-244,565213,049-53%-$24,456,500
D
2019-06-13
DGXGuinan MarkEVP, CFOS - Sale+OE$100.00-73,00566,017-53%-$7,300,500
D
2019-04-24
DGXDavis J. E.EVP, General DiagnosticsS - Sale+OE$95.00-47,57436,534-57%-$4,519,530
2019-04-08
DGXDavis J. E.EVP, General DiagnosticsS - Sale$90.29-8,00036,534-18%-$722,332
D
2019-04-04
DGXDoherty Catherine T.SVP, Group Exec. Clin. Fran.S - Sale+OE$90.59-66,38271,450-48%-$6,013,739
2019-03-04
DGXPrevoznik Michael ESVP, GCS - Sale$86.81-3,37344,467-7%-$292,810
2019-03-04
DGXCunningham EverettSVP, CommercialS - Sale$86.81-3,89239,032-9%-$337,865
M
2019-02-26
DGXPrevoznik Michael ESVP, GCS - Sale$86.65-1,41244,462-3%-$122,352
M
2019-02-26
DGXCunningham EverettSVP, CommercialS - Sale$86.64-1,49638,921-4%-$129,613
2019-02-25
DGXPrevoznik Michael ESVP, GCS - Sale$88.23-33646,780-1%-$29,645
2019-02-25
DGXCunningham EverettSVP, CommercialS - Sale$88.23-32641,529-1%-$28,763
D
2019-02-22
DGXWilensky Gail RDirS - Sale+OE$87.78-8,00026,604-23%-$702,216
D
2018-07-10
DGXPrevoznik Michael ESVP, GCS - Sale+OE$113.06-30,78044,706-41%-$3,480,141
D
2018-07-10
DGXCunningham EverettSVP, CommercialS - Sale+OE$112.00-40,32838,877-51%-$4,516,736
D
2018-07-02
DGXCunningham EverettSVP, CommercialS - Sale+OE$109.67-68,06938,877-64%-$7,465,043
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top